ERG IHC without interpretation
Use
This immunohistochemical (IHC) test performs the technical staining for ERG, a transcription factor whose expression can indicate the presence of a TMPRSS2‑ERG gene rearrangement often seen in prostate cancer; interpretation of the stain must be done by a qualified pathologist in the context of clinical history and other diagnostic data.
Special Instructions
Technical component only; no pathologist interpretation is included—order PATHC for full diagnostic evaluation; positive and negative controls are verified; best practice includes using slides cut within 6 weeks to preserve immunoreactivity.
Limitations
Age of paraffin sections may affect immunoreactivity; slide surface chemistry (e.g., charge, environmental factors) may alter staining; improper storage or handling of slides (high humidity, heat, plastics) may lead to inconsistent staining.
Methodology
Immunoassay (IHC)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Not provided.